Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Alifrangis

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Oncology|December 25, 2025
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trialKarim Fizazi, Fred Saad, Teresa Alonso-Gordoa, et al.
Journal of the National Cancer Institute|February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world studyKyle M Rose, Rachel Pham, Niki M Zacharias, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Oncology|December 25, 2025
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trialKarim Fizazi, Fred Saad, Teresa Alonso-Gordoa, et al.
Journal of the National Cancer Institute|February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world studyKyle M Rose, Rachel Pham, Niki M Zacharias, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Pageof 6